Erin Radominski
Acute Care · Dayton, OHNPI 1659865103
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 242 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 242 payments — averaging $21.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$856
- Sanofi$604
- Regeneron Healthcare Solutions, Inc.$529
- Boehringer Ingelheim$322
- Amgen$213
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,96395%
- Education$2365%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 38 | $1,105 |
| GSK | 55 | $856 |
| Sanofi | 30 | $604 |
| Regeneron Healthcare Solutions, Inc. | 21 | $529 |
| Boehringer Ingelheim | 16 | $322 |
| Amgen | 11 | $213 |
| Axsome Therapeutics, Inc. | 12 | $192 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $162 |
| Actelion Pharmaceuticals US, Inc. | 4 | $148 |
| Insmed, Inc. | 6 | $137 |
| Grifols USA, LLC | 7 | $127 |
| Lilly USA, LLC | 2 | $114 |
| United Therapeutics Corporation | 4 | $76 |
| Mallinckrodt Hospital Products Inc. | 3 | $73 |
| Bayer | 4 | $70 |
| Sanofi-aventis U.S. LLC | 1 | $62 |
| Baxter Healthcare | 3 | $62 |
| Philips North America LLC | 3 | $53 |
| Mylan Specialty L.p. | 3 | $46 |
| Pharming Healthcare, Inc. | 2 | $44 |
| Merck | 2 | $40 |
| Inspire Medical Systems, Inc. | 1 | $34 |
| Shionogi Inc | 1 | $29 |
| Genentech USA, Inc. | 1 | $21 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Inogen, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Novartis | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,199 in reported general payments places this provider in the 95th percentile of 1,101 acute care providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 341 | $354,193 |
| OfevNintedanib Esylate | 19 | $250,636 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 74 | $67,248 |
| Breo ElliptaFluticasone/Vilanterol | 46 | $24,001 |
| Spiriva RespimatTiotropium Bromide | 26 | $16,938 |
| SymbicortBudesonide/Formoterol Fumarate | 39 | $15,143 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 23 | $13,414 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 220 | $7,204 |
| Azithromycin | 284 | $3,836 |
| Pirfenidone | 11 | $3,437 |
| Roflumilast | 27 | $2,365 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 27 | $2,222 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 17 | $1,363 |
| Varenicline Tartrate | 13 | $1,355 |
| Montelukast Sodium | 131 | $792 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $856 | $378,194387 claims |
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat | $322 | $280,98868 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,105 | $82,390113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,101 acute care providers in Ohio.
Other acute care in Dayton
- Renee RothDayton$9K
- Grace HassanDayton$8K
- Carol GriffithDayton$7K
- Kearston TaylorDayton$5K
- Andrea RobinsonCleveland$149K
- Brittney BrowneMonroe$142K
- Jamie McGuireMiamisburg$86K
- Ileah ReichertColumbus$73K
- Davida PraterBeavercreek$46K
- Dawn FrenchAlliance$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.